Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36476
Title: | COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology | Authors: | Rosano, Giuseppe Jankowska, Ewa A. Ray, Robin Metra, Marco Abdelhamid, Magdy Adamopoulos, Stamatis Anker, Stefan D. Bayes-Genis, Antoni Belenkov, Yury Gal, Tuvia B. Boehm, Michael Chioncel, Ovidiu Cohen-Solal, Alain Farmakis, Dimitrios Filippatos, Gerasimos Gonzalez, Arantxa Gustafsson, Finn Hill, Loreena Jaarsma, Tiny Jouhra, Fadi Lainscak, Mitja Lambrinou, Ekaterini Lopatin, Yury Lund, Lars H. Milicic, Davor Moura, Brenda MULLENS, Wilfried Piepoli, Massimo F. Ponikowski, Piotr Rakisheva, Amina Ristic, Arsen Savarese, Gianluigi Seferovic, Petar Senni, Michele Thum, Thomas Tocchetti, Carlo G. Van Linthout, Sophie Volterrani, Maurizio Coats, Andrew J. S. |
Issue Date: | 2021 | Publisher: | WILEY | Source: | European journal of heart failure, 23 (11) , p. 1806 -1818 | Abstract: | Patients with heart failure (HF) who contract SARS-CoV-2 infection are at a higher risk of cardiovascular and non-cardiovascular morbidity and mortality. Regardless of therapeutic attempts in COVID-19, vaccination remains the most promising global approach at present for controlling this disease. There are several concerns and misconceptions regarding the clinical indications, optimal mode of delivery, safety and efficacy of COVID-19 vaccines for patients with HF. This document provides guidance to all healthcare professionals regarding the implementation of a COVID-19 vaccination scheme in patients with HF. COVID-19 vaccination is indicated in all patients with HF, including those who are immunocompromised (e.g. after heart transplantation receiving immunosuppressive therapy) and with frailty syndrome. It is preferable to vaccinate against COVID-19 patients with HF in an optimal clinical state, which would include clinical stability, adequate hydration and nutrition, optimized treatment of HF and other comorbidities (including iron deficiency), but corrective measures should not be allowed to delay vaccination. Patients with HF who have been vaccinated against COVID-19 need to continue precautionary measures, including the use of facemasks, hand hygiene and social distancing. Knowledge on strategies preventing SARS-CoV-2 infection (including the COVID-19 vaccination) should be included in the comprehensive educational programmes delivered to patients with HF. | Notes: | Jankowska, EA (corresponding author), Wroclaw Med Univ, Inst Heart Dis, Borowska 213, PL-50556 Wroclaw, Poland.; Jankowska, EA (corresponding author), Univ Hosp Wroclaw, Inst Heart Dis, Borowska 213, PL-50556 Wroclaw, Poland. ewa.jankowska@umed.wroc.pl |
Keywords: | failure;SARS-CoV-2;COVID-19;Vaccination | Document URI: | http://hdl.handle.net/1942/36476 | ISSN: | 1388-9842 | e-ISSN: | 1879-0844 | DOI: | 10.1002/ejhf.2356 | ISI #: | 000726365600002 | Rights: | 2021 European Society of Cardiology | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2022 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
COVID‐19 vaccination in patients with heart failure_ a position paper of the Heart Failure Association of the European Society of Cardiology.pdf | Published version | 207.96 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
37
checked on Oct 13, 2024
Page view(s)
26
checked on Jun 13, 2022
Download(s)
2
checked on Jun 13, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.